Sunitinib
Tumour Vessel Targeting Agents – Tyrosine Kinase Inhibitor of PDGFR-α and PDGFR-β, VEGFR-1,2,3, KIT and RET
Description of the anti-cancer agent sunitinib; a tyrosine kinase inhibitor of PDGFR-α and PDGFR-β, VEGFR-1,2,3, KIT and RET.
ESMO members: your membership includes full access to ESMO's Anti-Cancer Agents Factsheets. Sign in now to gain access to this page.
Not yet an ESMO member? Find out more about the benefits of becoming an ESMO member.